SUNMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin vs rituximab plus gemcitabine and oxaliplatin in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
| Autor: | Westin, Jason, Olszewski, Adam J, Fogliatto, Laura, Kim, Won Seog, Shin, Ho-Jin, Jeon, Young-Woo, Norasetthada, Lalita, Pavlovsky, Astrid, Rego, Eduardo, Wu, Hao, Yin, Shen, Batlevi, Connie Lee, Pham, Song, Penuel, Elicia M., Jing, Jing, Wei, Michael C., Budde, Lihua Elizabeth |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS7586-TPS7586, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|